Mental Health in the Oncology Setting: General Considerations and Treatment Tips
Lisa W. Goldstone, MS, PharmD, BCPS, BCPP
From University of Southern California School of Pharmacy, Los Angeles, California
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):243–246 |
© 2022 Harborside™
Patients with comorbid mental health and substance use disorders are at greater risk for mortality and have higher cancer care costs. At JADPRO Live Virtual 2021, Lisa W. Goldstone, MS, PharmD, BCPS, BCPP, talked through general considerations in the oncology setting for persons with comorbid mental health or substance use disorders, strategies for recognizing when patients with new or preexisting mental health symptoms or disorders may benefit from treatment and/or referral, and first and second-line pharmacotherapy options.
For access to the full length article, please sign in